Cytarabine
Cytarabine is a drug used to treat Leukemia, Acute Myeloid Leukemia, Lymphoma, and other conditions. Cytarabine is being actively studied in 204 studies and prior, has been studied in 391.
| Top Sponsors | Top Sites | Top Investigators |
|---|---|---|
| National Cancer Institute (NCI) | Roswell Park Cancer Institute | Amir Fathi |
| M.D. Anderson Cancer Center | Washington University School of Medicine | Prof. Dr. Hartmut Doehner |
| Children's Oncology Group | Children's National Medical Center | Julie M Vose, MD |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Recruiting
- Acute Myeloid Leukemia
- Cytarabine
- Gainesville, FloridaUniversity of Florida
2022-03-15
Mar 15, 2022H
Active, not recruiting
- Leukemia
- +2 more
- Selinexor
- +2 more
- Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
2021-11-15
Nov 15, 2021M
Not yet recruiting
- Leukemia, Myeloid, Acute
- Liposomal Annamycin
- Cytarabine
- Poznań, PolandSzpital Kliniczny Przemienienia Pańskiego Uniwersytetu Medyczneg
2022-04-05
Apr 5, 2022J
Completed
- Acute Myelogenous Leukemia
- +3 more
- Pevonedistat
- Cytarabine
- Miami, FloridaUniversity of Miami
2021-12-07
Dec 7, 2021W
Active, not recruiting
- Mantle Cell Lymphoma
- Bendamustine
- +7 more
- Saint Louis, MissouriWashington University School of Medicine
2022-02-02
Feb 2, 2022U
Terminated
- Acute Myeloid Leukemia
- Cytarabine
- +2 more
- Chicago, IllinoisUniversity of Illinois at Chicago
2021-07-01
Jul 1, 2021M
Recruiting
- Leukemia
- Cladribine
- +2 more
- Houston, TexasUniversity of Texas MD Anderson Cancer Center
2021-11-11
Nov 11, 2021W
Active, not recruiting
- Mantle Cell Lymphoma
- Bendamustine
- +6 more
- Saint Louis, MissouriWashington University School of Medicine
2021-05-21
May 21, 2021P
P
Recruiting
- Langerhans Cell Histiocytosis
- Cytarabine
- Beijing, ChinaPeking Union Medical College Hospital
2021-06-07
Jun 7, 2021B
Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
Recruiting
- Langerhans Cell Histiocytosis
- Cytarabine
- Vinblastine/prednisone
- San Diego, California
- +4 more
2021-06-02
Jun 2, 2021M
Active, not recruiting
- Acute Myeloid Leukemia
- +2 more
- Cytarabine
- +2 more
- Houston, TexasM D Anderson Cancer Center
2022-03-01
Mar 1, 2022M
Recruiting
- Acute Myeloid Leukemia
- Cytarabine
- +5 more
- Duarte, California
- +2 more
2022-01-21
Jan 21, 2022M
Recruiting
- Secondary Acute Myeloid Leukemia
- Cladribine
- +2 more
- Houston, TexasM D Anderson Cancer Center
2021-06-25
Jun 25, 2021M
S
Efficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AML
Not yet recruiting
- Acute Myeloid Leukemia
- +2 more
- Cladribine Injection
- +3 more
- Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
2020-12-15
Dec 15, 2020F
Recruiting
- Acute Myeloid Leukemia
- Myeloid Neoplasm
- Liposome-encapsulated Daunorubicin-Cytarabine
- +6 more
- Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
2022-03-15
Mar 15, 2022C
Not yet recruiting
- Acute Myelogenous Leukemia
- +2 more
- Fludarabine
- +2 more
- (no location specified)
2022-03-03
Mar 3, 2022N
Completed
- Acute Myeloid Leukemia (AML)
- cytarabine
- +2 more
- Los Angeles, California
- +5 more
2020-12-16
Dec 16, 2020V
Active, not recruiting
- Acute Myeloid Leukemia
- +6 more
- Cytarabine
- Vosaroxin
- New Haven, Connecticut
- +2 more
2021-09-08
Sep 8, 2021M
Active, not recruiting
- FLT3 Gene Mutation Negative
- +7 more
- Azacitidine
- +3 more
- Houston, TexasM D Anderson Cancer Center
2022-03-18
Mar 18, 2022C
Completed
- Acute Myeloid Leukemia
- Onvansertib
- +2 more
- Los Angeles, California
- +8 more
2022-01-04
Jan 4, 2022S
Completed
- Acute Myeloid Leukemia
- Cytarabine
- +4 more
- Palo Alto, California
- +7 more
2021-08-06
Aug 6, 2021G
Completed
- Acute Myeloid Leukemia (Relapsed/Refractory)
- Selinexor
- +2 more
- Frankfurt am Main, Hessen, Germany
- +2 more
2021-08-01
Aug 1, 2021R
Completed
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
- +6 more
- cytarabine
- lenalidomide
- Buffalo, New YorkRoswell Park Cancer Institute
2020-09-22
Sep 22, 2020